
AI-accelerated oncology drug discovery and precision therapy development
Visit Lantern PharmaLantern Pharma is an AI-driven platform specializing in accelerating oncology drug discovery and development. Its proprietary platform, RADR®, utilizes massive oncology-specific datasets and advanced machine learning algorithms to identify precision therapies, analyze patient genomic or biomarker data, and propose targeted clinical trials. The tool is designed for pharmaceutical companies, research organizations, and partners seeking innovative and cost-effective solutions for cancer drug development.
Visit Lantern Pharma's official website for product details and getting started.
Detailed information about the RADR® platform and its capabilities in oncology drug discovery.
Information on the targeted clinical trials proposed by Lantern Pharma based on their AI-driven analysis.
Details on how pharmaceutical companies and research organizations can collaborate with Lantern Pharma.